Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma

Overview of attention for article published in Journal for Immunotherapy of Cancer, September 2015

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 25,969 followers.

RT @sitcancer: NEW #immunotherapy #biomarkers article available via Journal for Immunotherapy of Cancer http://t.co/3Tj4ShHReH #melanoma

RT @sitcancer: NEW #immunotherapy #biomarkers article available via Journal for Immunotherapy of Cancer http://t.co/3Tj4ShHReH #melanoma

RT @sitcancer: NEW #immunotherapy #biomarkers article available via Journal for Immunotherapy of Cancer http://t.co/3Tj4ShHReH #melanoma

NEW #immunotherapy #biomarkers article available via Journal for Immunotherapy of Cancer http://t.co/3Tj4ShHReH #melanoma

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.